JS-K, a nitric oxide pro-drug, regulates growth and apoptosis through the ubiquitin-proteasome pathway in prostate cancer cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Works matching AU Ke, Longzhi
Results: 4
1
2
JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
3
JS-K enhances chemosensitivity of prostate cancer cells to Taxol via reactive oxygen species activation.
- Published in:
- Oncology Letters, 2019, v. 17, n. 1, p. 757
- By:
- Publication type:
- Article
4
JS-K promotes apoptosis by inducing ROS production in human prostate cancer cells.
- Published in:
- Oncology Letters, 2017, v. 13, n. 3, p. 1137, doi. 10.3892/ol.2016.5535
- By:
- Publication type:
- Article